JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia [2]

British Journal of Haematology

Volumn 138, Issue 6, 2007, Pages 813-814

  Rossi, Davide ^a   Cresta, Stefania ^a   Destro, Tamara ^a   Vendramin, Chiara ^a   Bocchetta, Simone ^a   De Paoli, Lorenzo ^a   Cerri, Michaela ^a   Lunghi, Monia ^a   Gaidano, Gianluca ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Chronic myeloproliferative disorders; JAK2 mutation; Pulmonary embolism; Thrombophilia; Venous thromboembolism

Indexed keywords

MOLECULAR MARKER;

ADULT; AGED; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; HEMOPHILIA; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; JAK2V617F GENE; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MYELOPROLIFERATIVE DISORDER; PATIENT REFERRAL; PATIENT SELECTION; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; SCREENING TEST; SEROLOGY; SEX RATIO; VENOUS THROMBOEMBOLISM;

ADULT; AGED; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; PULMONARY EMBOLISM; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 34548154461     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06715.x     Document Type: Letter

References (10)

1. Boissinot, M., Lippert, E., Girodon, F., Dobo, I., Fouassier, M., Masliah, C., Praloran, V. Hermouet, S. (2006) Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis. Blood, 108, 3223 3224.
2. Campbell, P.J., Scott, L.M., Buck, G., Wheatley, K., East, C.L., Marsden, J.T., Duffy, A., Boyd, E.M., Bench, A.J., Scott, M.A., Vassiliou, G.S., Milligan, D.W., Smith, S.R., Erber, W.N., Bareford, D., Wilkins, B.S., Reilly, J.T., Harrison, C.N., Green, A.R., United Kingdom Myeloproliferative Disorders Study Group, Medical Research Council Adult Leukaemia Working Party, Australasian Leukaemia and Lymphoma Group (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 366, 1945 1953.
3. Colaizzo, D., Amitrano, L., Iannaccone, L., Vergura, P., Cappucci, F.C., Grandone, E., Guardascione, M.A. Margaglione, M. (2007) Gain of function gene mutations and venous thromboembolism: distinct roles in different clinical settings. Journal of Medical Genetics, doi:
4. De Stefano, V., Fiorini, A., Rossi, E., Za, T., Farina, G., Chiusolo, P., Sica, S. Leone, G. (2007) Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. Journal of Thrombosis and Haemostasis, 5, 708 714.
5. Harrison, C.N., Campbell, P.J., Buck, G., Wheatley, K., East, C.L., Bareford, D., Wilkins, B.S., van der Walt, J.D., Reilly, J.T., Grigg, A.P., Revell, P., Woodcock, B.E., Green, A.R., United Kingdom Medical Research Council Primary Thrombocythemia 1 Study (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. The New England Journal of Medicine, 353, 33 45.
6. Marchioli, R., Finazzi, G., Landolfi, R., Kutti, J., Gisslinger, H., Patrono, C., Marilus, R., Villegas, A., Tognoni, G. Barbui, T. (2005) Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. Journal of Clinical Oncology, 23, 2224 2232.
7. Primignani, M., Barosi, G., Bergamaschi, G., Granelli, U., Fabris, F., Reati, R., Dell'Era, A., Bucciarelli, P. Mannucci, P.M. (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology, 44, 1528 1534.
8. Regina, S., Herault, O., D'Alteroche, L., Binet, C. Gruel, Y. (2007) JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. Journal of Thrombosis and Haemostasis, 5, 859 861.
9. Remacha, A.F., Estivill, C., Sarda, M.P., Mateo, J., Souto, J.C., Canals, C., Nomdedeu, J. Fontcuberta, J. (2007) The V617F mutation of JAK2 is very uncommon in patients with thrombosis. Haematologica, 92, 285 286.
10. Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Rambaldi, A., Barosi, G., Marchiali, R., Marfisi, R.M., Finazzi, G., Guerini, V., Fabris, F., Randi, M.L., De Stefano, V., Caberlon, S., Tafuri, A., Ruggeri, M., Specchia, G., Liso, V., Rossi, E., Pogliani, E., Gugliotta, L., Bosi, A. Barbui, T. (2007) Clinical profile of homozygous JAK2V617F mutation in patients with polycythemia vera or essential thrombocythemia. Blood, doi:.